2 results
Approved WMORecruiting
Primary: • Demonstrate superior efficacy (increased progression-free survival [PFS]) of MEK162 vs. physician*s choice of selected chemotherapies (liposomal doxorubicin, paclitaxel and topotecan)Key Secondary: • Demonstrate superior efficacy (…
Approved WMORecruiting
The objective of the study is to develop and test a blended vision-specific E-health-based cognitive behavioral & self-management intervention (*E-nergEYEze*). Our specific goals are: (1) to further develop E-nergEYEze for visually impaired…